Sophia Kamran, MD

Articles by Sophia Kamran, MD

Kamran on the Shift Towards Early Salvage Radiation After Prostatectomy

BySophia Kamran, MD

April 28th 2025

Proactive Patient Communication: Early Discussion on Salvage Therapies for Prostate Cancer

BySophia Kamran, MD

April 28th 2025

Sophia Kamran, MD, discusses how salvage therapy after biochemical recurrence may improve outcomes for patients with prostate cancer.

Anticipating Expanded Uses of Radiotherapy in Urothelial Carcinoma

BySophia Kamran, MD

August 8th 2022

Sophia Kamran, MD, discusses future roles that radiation oncology will play in combination with resection and targeted therapy in urothelial carcinoma.

Trimodality Therapy Plus Atezolizumab Investigated for Bladder Cancer

BySophia Kamran, MD

May 5th 2022

Sophia Kamran, MD, discusses the research supporting the use of trimodality therapy with immunotherapy for patients with urothelial cancer.

Sophia Kamran, MD

Articles by Sophia Kamran, MD

Kamran on the Shift Towards Early Salvage Radiation After Prostatectomy

Proactive Patient Communication: Early Discussion on Salvage Therapies for Prostate Cancer

Anticipating Expanded Uses of Radiotherapy in Urothelial Carcinoma

Trimodality Therapy Plus Atezolizumab Investigated for Bladder Cancer

Latest Updated Articles

Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

Behind the FDA Approval: Isatuximab On-Body Injector Supports ‘Patient-Centric’ Priorities in Multiple Myeloma

Safusidenib Shows Durable Responses in IDH1-Mutant Glioma at 3-Year Follow-Up

CheckMate 9LA Data Push Toward Dual Checkpoint Blockade in PD-L1–Negative NSCLC

Thoracic Radiotherapy Added to Atezolizumab Raised Toxicity in SCLC

De-Escalated Neoadjuvant HER2-Targeted Therapy Shows Durable 5-Year Survival